Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates

Budesonide nebulization in the treatment of neonatal ventilator associated pneumonia

“…Luo HJ et al found budesonide can improve pulmonary ventilation and diffuse function in the treatment of neonatal aspiration pneumonia. 15 For premature infants, 16 , 17 budesonide nebulization can relieve mechanical ventilation induced airway inflammation and prevent the incidence of bronchopulmonary dysplasia.…”

Budesonide nebulization in the treatment of neonatal ventilator associated pneumonia

“…Luo HJ et al found budesonide can improve pulmonary ventilation and diffuse function in the treatment of neonatal aspiration pneumonia. 15 For premature infants, 16 , 17 budesonide nebulization can relieve mechanical ventilation induced airway inflammation and prevent the incidence of bronchopulmonary dysplasia.…”

Effectiveness and safety of early combined utilization of budesonide and surfactant by airway for Bronchopulmonary dysplasia prevention in premature infants with RDS: A meta-analysis

“…7 Therefore, delivery of steroids directly to lungs, by inhalation or by intratracheal instillation may be an alternative choice. 9,10 Airway administration of budesonide was reported to decrease the incidence of BPD in premature infants, 11,12 but it was also shown to increase mortality. 13 Surfactant is now commonly used for premature infants with RDS.…”

Update on Postnatal Steroids

“…There have been 2 relevant systematic reviews: 1 comparing inhaled with systemic steroids to prevent CLD in ventilated preterm neonates [23] and 1 comparing these routes of administration to treat CLD in ventilated preterm infants [24]. The duration of mechanical ventilation was longer with early (<2 weeks) inhaled steroids compared to systemic steroids (typical mean difference 4 days, 95% CI 0.2-8).…”

“…Neither early inhaled steroids nor early systemic steroids can be recommended as part of standard practice for ventilated preterm infants. Because they might have fewer adverse effects than systemic steroids, further randomized controlled trials of inhaled steroids are needed that address the risk/benefit ratio of different delivery techniques, dosing schedules, and long-term effects, with particular attention to neurodevelopmental outcome [23]. …”

Budesonide nebulization in the treatment of neonatal ventilator associated pneumonia

“…Luo HJ et al found budesonide can improve pulmonary ventilation and diffuse function in the treatment of neonatal aspiration pneumonia. 15 For premature infants, 16 , 17 budesonide nebulization can relieve mechanical ventilation induced airway inflammation and prevent the incidence of bronchopulmonary dysplasia.…”

Effectiveness and safety of early combined utilization of budesonide and surfactant by airway for Bronchopulmonary dysplasia prevention in premature infants with RDS: A meta-analysis

“…7 Therefore, delivery of steroids directly to lungs, by inhalation or by intratracheal instillation may be an alternative choice. 9,10 Airway administration of budesonide was reported to decrease the incidence of BPD in premature infants, 11,12 but it was also shown to increase mortality. 13 Surfactant is now commonly used for premature infants with RDS.…”

Update on Postnatal Steroids

“…There have been 2 relevant systematic reviews: 1 comparing inhaled with systemic steroids to prevent CLD in ventilated preterm neonates [23] and 1 comparing these routes of administration to treat CLD in ventilated preterm infants [24]. The duration of mechanical ventilation was longer with early (<2 weeks) inhaled steroids compared to systemic steroids (typical mean difference 4 days, 95% CI 0.2-8).…”

“…Neither early inhaled steroids nor early systemic steroids can be recommended as part of standard practice for ventilated preterm infants. Because they might have fewer adverse effects than systemic steroids, further randomized controlled trials of inhaled steroids are needed that address the risk/benefit ratio of different delivery techniques, dosing schedules, and long-term effects, with particular attention to neurodevelopmental outcome [23]. …”

Budesonide nebulization in the treatment of neonatal ventilator associated pneumonia

“…Luo HJ et al found budesonide can improve pulmonary ventilation and diffuse function in the treatment of neonatal aspiration pneumonia. 15 For premature infants, 16 , 17 budesonide nebulization can relieve mechanical ventilation induced airway inflammation and prevent the incidence of bronchopulmonary dysplasia.…”

Effectiveness and safety of early combined utilization of budesonide and surfactant by airway for Bronchopulmonary dysplasia prevention in premature infants with RDS: A meta-analysis

“…7 Therefore, delivery of steroids directly to lungs, by inhalation or by intratracheal instillation may be an alternative choice. 9,10 Airway administration of budesonide was reported to decrease the incidence of BPD in premature infants, 11,12 but it was also shown to increase mortality. 13 Surfactant is now commonly used for premature infants with RDS.…”

Update on Postnatal Steroids

“…There have been 2 relevant systematic reviews: 1 comparing inhaled with systemic steroids to prevent CLD in ventilated preterm neonates [23] and 1 comparing these routes of administration to treat CLD in ventilated preterm infants [24]. The duration of mechanical ventilation was longer with early (<2 weeks) inhaled steroids compared to systemic steroids (typical mean difference 4 days, 95% CI 0.2-8).…”

“…Neither early inhaled steroids nor early systemic steroids can be recommended as part of standard practice for ventilated preterm infants. Because they might have fewer adverse effects than systemic steroids, further randomized controlled trials of inhaled steroids are needed that address the risk/benefit ratio of different delivery techniques, dosing schedules, and long-term effects, with particular attention to neurodevelopmental outcome [23]. …”